Literature DB >> 8021592

Phylogenetic relationship between human immunodeficiency virus type 1 (HIV-1) long terminal repeat natural variants present in the lymph node and peripheral blood of three HIV-1-infected individuals.

M Ait-Khaled1, V C Emery.   

Abstract

PCR has been used to amplify a 540 base pair fragment of the human immunodeficiency virus type 1 (HIV-1) long terminal repeat region encompassing the U5/R/U3 regions from proviral HIV DNA that was present in the lymph nodes and peripheral blood mononuclear cells of three HIV-infected individuals. The resulting PCR products were cloned and the DNA sequence of multiple clones from each reaction was determined to enable the distribution and phylogenetic relationship between the variants in each body site to be assessed. The results of bootstrapped parsimony phylogenetic analyses showed that a distinct polarization was evident between peripheral blood and lymph node variants in the patient who possessed a histologically intact lymph node. In contrast, similar analyses conducted on samples from two patients with extensive lymph node disruption showed similar variants in lymph node and peripheral blood. In the patient with an intact lymph node, lymph node variants were significantly more heterogeneous than those present in blood samples taken either simultaneously or 11 months later. No differences in heterogeneity between lymph node and peripheral blood were observed in patients with disrupted lymph nodes. The significance of these results for our understanding of HIV pathogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021592     DOI: 10.1099/0022-1317-75-7-1615

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.

Authors:  M C Estable; B Bell; A Merzouki; J S Montaner; M V O'Shaughnessy; I J Sadowski
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

2.  Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.

Authors:  W Maury; S Perryman; J L Oaks; B K Seid; T Crawford; T McGuire; S Carpenter
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.

Authors:  Tricia H Hogan; Devin L Stauff; Fred C Krebs; Suzanne Gartner; Shane J Quiterio; Brian Wigdahl
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

4.  Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.

Authors:  O J Cohen; G Pantaleo; M Holodniy; S Schnittman; M Niu; C Graziosi; G N Pavlakis; J Lalezari; J A Bartlett; R T Steigbigel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

5.  Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection.

Authors:  B Murphy; C Hillman; S McDonnel
Journal:  Virus Res       Date:  2013-11-28       Impact factor: 3.303

6.  Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.

Authors:  Tricia H Burdo; Suzanne Gartner; David Mauger; Brian Wigdahl
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

7.  HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity.

Authors:  Michael R Nonnemacher; Vanessa Pirrone; Rui Feng; Brian Moldover; Shendra Passic; Benjamas Aiamkitsumrit; Will Dampier; Adam Wojno; Evelyn Kilareski; Brandon Blakey; Tse-Sheun Jade Ku; Sonia Shah; Neil T Sullivan; Jeffrey M Jacobson; Brian Wigdahl
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.